TITLE:

EMA: First statistics on PRIME, released

BRIEF:

As reported on its website, the European Medicines Agency (EMA) recently released the outcome of the assessment of the first batch of applications received from medicine developers for its PRIME (PRIority MEdicines) scheme, a new initiative that aims to foster research on and development of medicines that have the potential to address an unmet medical need.